From: Sent: To: Cc: Subject: Attach: Bruce Jarnot <jarnotb@api.org> Thursday, February 5, 2004 3:41 PM (GMT) benzconsort-tc@listserve.api.org Matt Todd <ToddM@api.org> BHRC-TC conference call ...
refid# gbg8GOBmQ7p5L63GJV5yeK7NV3 pages
From: Sent: To: Cc: Subject: Cagen, Stuart Z SCC <stuart.cagen@shell.com> Tuesday, April 15,2003 12:07 AM (GMT) Tholstrup, Susan C SCC <susan.tholstrup@shell.com> Tsai, Shan SP SHLOIL-SHLOIL-HE <Shan.Tsai@shell.com>; Clegg, Patsy M SCCCHSE-PC <patsy.c1egg@shell.com>; Owen, David DE SC-CHSE-DO <david.owen@shell.com> RE: Benzene Shanghai Susan: There is an action for API staff to send me yearly budget spreadsheets from the University of Colorado and from Applied Health Sciences.
refid# e7pzdX4DVwKE7yJ4Qyeb1G4Bp4 pages
To: From: Cc: Bcc: Received Date: Subject: Steup, David R Alliance <lO=SHELLlOU=MSXSSC/CN=PARTCOMP/CN=EQUILONlCN =DRSTEUPEQ> Mallett, Anthony AK SC-CHSE-TM <lO=SHELLlOU=OPC/CN=RECIPI ENTS/CN=WYAMJD> Cagen, Stuart SZ SCC <lO=SHELLlOU=MSXSCC/CN=RECI PI ENTS/CN=SC724012>; David Owen <lO=SHELLlOU=OPC/CN=RECIPI ENTS/CN=SNDOW4>; Patsy Hill <lO=SHELLlOU=MSXSOPC/CN=RECIPI ENTS/CN=PH197432> ; Robert Priston <lO=SHELLlOU=OPC/CN=RECIPIENTS/CN=SNRPR1> 2000-06-0218:22:54 GMT API I benzene proposal David, fyi some breaking news with respect to the Shanghai proposal.
refid# QXnavp6VzJ2w9d63Eoad2NYJL1 page
To: From: Cc: Bcc: Received Date: Subject: 'Lorraine Twerdok' dwerdokl@api.org> Cagen, Stuart SZ SCC <lO=SHELLlOU=MSXSCC/CN=RECI PI ENTS/CN=SC724012> 2000-12-0721 :49:11 GMT RE: POSTPONED - Benzene Research Consortium Stakeholders Meeting - D December 1 4, 2000 Lorraine: 1) I am available on the 16th of January so count me in. 2) Is postponement final?
refid# NNdRqLR0Z0z09wBBEbJ780Xrb4 pages
Draft - December 12, 2001 Executive Summary Scientific Review Panel Protocol Review: Analysis Of Disease Progression For Aplastic Anemia, Myelodysplastic Syndrome, Acute Myelogenous Leukemia And Benzene Poisoning In Shanghai, China The purpose of this document is to summarize the detailed discussions with the independent Scientific Review Panel (SRP) that have taken place regarding the subject study.
refid# 5D9JwenneodJzgaO066mdz6M03 pages
Oct 25, 2000 e-mail sent to Nancy, Debra, Steve Just got off the conference call discussing allocation of cost for the Benzene Shanghai study.
refid# bakZq2xKzw4ZXKej2qnwZam931 page
BHRC OVERSIGHT, TECHNICAL, COMMUNICATIONS COMMITTEES CALL MINUTES November 4, 2009 Attendees: Don Burnett, BP Patsy Clegg (Chair), Shell Brian Doll, ExxonMobil Howard Feldman, API Mark Fitzsimmons, Steptoe and Johnson Jennifer Galvin, ConocoPhillips Laura Keating, ExxonMobil Eric Stine, Chevron Russ White, API Guest: Rob Schnatter, ExxonMobil Quorum Present Antitrust Guidelines reviewed Decisions/Actions: 1.
refid# QgE6MaqVK8vMjx43M78aBG2g72 pages
Benzene Health Research Consortium Oversight Committee Meeting Agenda November 10-11, 2003 ChevronTexaco 300 Block California Street San Francisco, CA Patrick provide room details and how to enter building, security, etc PURPOSE OF MEETING: Budget revision and approval Financial Reporting Review Contract Reviews Recruitment - Funding and Non-Funding Communications Update 2nd Annual Meeting - Preplanning Attendees: Patrick Beatty Brian Doll Don Burnette Mike Johnston Patsy Clegg Stuart Cagen Lynn Russo, part-time by phone Lorraine Twerdok Monday, November 10 1:00 Welcome Patrick Emergency Review Patrick Anti-trust API Roll Call - Establish Quorum Lorraine Review & Approve Draft OC Minutes Lorraine Agenda Review Don Added (1) schedule next call/meeting; (2) committee chairs 1: 15 Minutes Review Lorraine study.
refid# LpX5oegz5KmvvwmR109RGM2nd4 pages
To: Tsai, Shan SP SHLOIL-SPS </O=SHE LUOU=MSXSOC/CN=RE CI PI ENTS/CN=ST196949> From: lynn. b. russo@exxonmobil.com <lynn. b. russo@exxonmobil.com> Cc: Cagen, Stuart Z SCC </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=SC724012>; pmclegg@shellus.com <pmclegg@shellus.com> Bcc: Received Date: 2002-10-1717:28:27 GMT Subject: Sinopec and Petrochina As discussed at today's call.
refid# 37QZ9GDJOmKnVNjMrwBJEw1L65 pages
To: Jennifer Galvin (E-mail)<jbga@ppco.com> From: Lorraine Twerdok <Twerdokl@api.org> Cc: Mike Johnston (E-mail)<mike.d.johnston@conocophillips.com>; Clegg, Patsy M SCC-CHSE-PC <patsy.clegg@shell.com>; Madeleine Sellouk <Sellouk@api.org>; Cagen, Stuart Z SCC-HSE <stuart.cagen@shell.com> Bcc: Received Date: 2004-07-30 18: 11 :17 GMT Subject: Jennifer Galvin canceling for SHS Annual Meeting Hi Jennifer I'm disappointed that you will not be able to attend the SHS Annual Meeting - it's a great study, and the Annual meeting puts all of the pieces together for the sponsors.
refid# yrL79g5pGR1L4Zj10jxbkD4JE2 pages
Benzene Health Research Consortium 4004 Financial Report Overview Case Diagnosis: JCML clinical lab continues to increase diagnostic throughput, operating above 100% capacity, and processing 30% more cases than anticipated with 99+% concordance between primary Case Accrual: Cases are being accrued at optimal rate from all participating hospitals, with 500+ AML and External Review Panels: The SRP reviewed 2 (of 3) SHS presentations from the Munich Benzene Fund Balance at API 4Q04: $2,823, 1691 Irons Field Expenses: New T&E contract executed in 4004.
refid# LKQBEV12k9j2GjmNNXLLbjXjQ57 pages
DRAFT CINPATHOGEN DELIVERABLES Within five calendar days of the receipt of funds, Cinpathogen will identify progress milestones to be achieved in the second quarter, 2007; 1.
refid# mmqxDKzQzQJLdng3v3EVJxNYd2 pages
Subject: ??
refid# k6opmrMjneZNRzB93q4mDjBJV1 page
I.
refid# mBy2obOz2dXwJGOQJJxXvwdEd1 page
Attachments: DP ME Progress Report Jul-2007rev.pdf SH ELL-MCCLU RG-059270
refid# zbve97pVk4dazEO4JbGEmQ52B1 page